Direxion Daily S&P Biotech Bull 3X Shares (LABU) Stock Overview
Explore Direxion Daily S&P Biotech Bull 3X Shares’s financial performance, market position, analyst ratings, and future outlook.
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
Key Financials
Key Financials
Market Cap
1.6B
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
0.00%
LABU Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Direxion Daily S&P Biotech Bull 3X Shares's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of LABU on the AMEX shows an RSI of 59.72, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $15.64 for the AMEX listing.
Key metrics behind Direxion Daily S&P Biotech Bull 3X Shares's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 1.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LABU on the AMEX.